Cell Signaling Technology

Phospho-TrkA (Tyr490) Antibody

#9141 · $366

100
Citing papers
6.1k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation13Cancer-related Molecular Pathways8Nerve injury and regeneration7Neuroscience and Neuropharmacology Research7Cancer-related molecular mechanisms research6Cell death mechanisms and regulation6Circular RNAs in diseases6RNA Research and Splicing6

Papers citing this product

1
Toll-like Receptors Induce a Phagocytic Gene Program through p38
The Journal of Experimental Medicine·2003·428 cit.·DOI
2
Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP
Human Molecular Genetics·2011·316 cit.·DOI
3
Regulation of Akt Signaling by D<sub>2</sub>and D<sub>3</sub>Dopamine Receptors<i>In Vivo</i>
Journal of Neuroscience·2007·265 cit.·DOI
4
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
The EMBO Journal·2011·262 cit.·DOI
5
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
Carcinogenesis·2010·247 cit.·DOI
6
MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2
PLoS ONE·2010·245 cit.·DOI
7
MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer
Oncogene·2012·218 cit.·DOI
8
An estrogen receptor α suppressor, microRNA‐22, is downregulated in estrogen receptor α‐positive human breast cancer cell lines and clinical samples
FEBS Journal·2010·161 cit.·DOI
9
Impaired Cerebellar Development and Function in Mice Lacking CAPS2, a Protein Involved in Neurotrophin Release
Journal of Neuroscience·2007·153 cit.·DOI
10
Expression patterns of microRNAs associated with CML phases and their disease related targets
Molecular Cancer·2011·142 cit.·DOI